141 related articles for article (PubMed ID: 2884120)
1. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.
Johnson M; Stone DM; Hanson GR; Gibb JW
Eur J Pharmacol; 1987 Mar; 135(2):231-4. PubMed ID: 2884120
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
Johnson M; Hanson GR; Gibb JW
Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
[TBL] [Abstract][Full Text] [Related]
3. Fetal substantia nigra grafts. Effect on dopamine receptors in the rat corpus striatium.
Korfali E; Knowles WD; Uysal S; Ulus IH; Ozmen T
Cleve Clin J Med; 1989 May; 56(3):259-62. PubMed ID: 2568188
[TBL] [Abstract][Full Text] [Related]
4. Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system.
Sonsalla PK; Gibb JW; Hanson GR
Neuropharmacology; 1986 Nov; 25(11):1221-30. PubMed ID: 2432440
[TBL] [Abstract][Full Text] [Related]
5. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues.
Dunnett SB; Hernandez TD; Summerfield A; Jones GH; Arbuthnott G
Exp Brain Res; 1988; 71(2):411-24. PubMed ID: 2901978
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway.
Nishino H; Hashitani T; Kumazaki M; Sato H; Furuyama F; Isobe Y; Watari N; Kanai M; Shiosaka S
Brain Res; 1990 Nov; 534(1-2):83-93. PubMed ID: 1981488
[TBL] [Abstract][Full Text] [Related]
7. Nigrostriatal reconstruction after 6-OHDA lesions in rats: combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts.
Dunnett SB; Rogers DC; Richards SJ
Exp Brain Res; 1989; 75(3):523-35. PubMed ID: 2568267
[TBL] [Abstract][Full Text] [Related]
8. Neonatal dopamine-rich grafts and 6-OHDA lesions independently provide partial protection from the adult nigrostriatal lesion syndrome.
Rogers DC; Dunnett SB
Behav Brain Res; 1989 Aug; 34(1-2):131-46. PubMed ID: 2504223
[TBL] [Abstract][Full Text] [Related]
9. Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats.
Marek GJ; Vosmer G; Seiden LS
Pharmacol Biochem Behav; 1990 May; 36(1):187-90. PubMed ID: 2112259
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
Robertson GS; Fine A; Robertson HA
Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
[TBL] [Abstract][Full Text] [Related]
11. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
Kogan FJ; Nichols WK; Gibb JW
Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
[TBL] [Abstract][Full Text] [Related]
12. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
13. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.
Hotchkiss AJ; Gibb JW
J Pharmacol Exp Ther; 1980 Aug; 214(2):257-62. PubMed ID: 6104722
[TBL] [Abstract][Full Text] [Related]
15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
16. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
Schmidt CJ; Gibb JW
Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
[TBL] [Abstract][Full Text] [Related]
17. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
Melamed E; Hefti F; Wurtman RJ
Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
[TBL] [Abstract][Full Text] [Related]
18. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
19. Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions.
Walker PD; Riley LA; Hart RP; Jonakait GM
Brain Res; 1991 Aug; 557(1-2):31-6. PubMed ID: 1720996
[TBL] [Abstract][Full Text] [Related]
20. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
